Literature DB >> 20505794

Safety of dual antiplatelet therapy in daily cardiology practice.

F W A Verheugt1.   

Abstract

Year:  2010        PMID： 20505794      PMCID： PMC2871741          DOI： 10.1007/BF03091767

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  15 in total

1.  Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry.

Authors:  A Przybylski; P Derejko; W Kwaśniewski; D Urbańczyk-Swić; J Zakrzewska; W Orszulak; M Orczykowski; A Filipecki; L Szumowski; F Walczak; M Trusz-Gluza
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

2.  Good old warfarin for stroke prevention in atrial fibrillation.

Authors:  Freek W A Verheugt
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

3.  Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

Authors:  Jean-Pierre Bassand; Christian W Hamm; Diego Ardissino; Eric Boersma; Andrzej Budaj; Francisco Fernández-Avilés; Keith A A Fox; David Hasdai; E Magnus Ohman; Lars Wallentin; William Wijns
Journal:  Eur Heart J       Date:  2007-06-14       Impact factor: 29.983

4.  Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

Authors:  Z M Chen; L X Jiang; Y P Chen; J X Xie; H C Pan; R Peto; R Collins; L S Liu
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

5.  Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis.

Authors:  Emile Ferrari; Mustapha Benhamou; Pierre Cerboni; Baudouy Marcel
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

6.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

7.  Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.

Authors:  Keith A A Fox; Shamir R Mehta; Ron Peters; Feng Zhao; Nasser Lakkis; Bernard J Gersh; Salim Yusuf
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

8.  Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.

Authors:  Juan M Ruiz-Nodar; Francisco Marín; José Antonio Hurtado; José Valencia; Eduardo Pinar; Javier Pineda; Juan Ramón Gimeno; Francisco Sogorb; Mariano Valdés; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2008-02-26       Impact factor: 24.094

Review 9.  New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?

Authors:  Frans Van de Werf
Journal:  Eur Heart J       Date:  2009-06-01       Impact factor: 29.983

10.  Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).

Authors:  Willem Dewilde; Jurriën Ten Berg
Journal:  Am Heart J       Date:  2009-11       Impact factor: 4.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.